If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE Trails Peers Amid Thanksgiving Profit Taking

Thu, 26th Nov 2020 16:53

(Alliance News) - Stock prices in London ended in the red on Thursday, drifting lower during what was a muted session due to markets in the US being closed over Thanksgiving.

"Without a US intervention, the European markets struggled to put on a worthwhile display this Thursday afternoon, too busy mulling over what they're thankful for," Spreadex analyst Connor Campbell explained.

The FTSE 100 index lost 0.4%, or 28.16 points to close at 6,362.93. The FTSE 250 gave back 0.9%, or 173.05 points, at 19,396.34 but the AIM All-Share closed 0.6% higher, rising 6.27 points to 1,038.03.

The Cboe UK 100 index closed down 0.4%, or 2.49 points, at 633.56. The Cboe 250 ended down 1.1% at 16,743.28, and the Cboe Small Companies lost 0.5% at 11,449.54.

The CAC 40 closed fractionally higher on Thursday, while the DAX 30 in Frankfurt ended up 0.1%.

Traders that did take part in the muted session on Thursday turned to profit taking, making the most of Tuesday's bumper gains for equities, noted CMC Markets analyst David Madden.

"The mood was bullish earlier in the week as traders welcomed the upbeat coronavirus vaccine news from AstraZeneca-Oxford University," Madden explained.

"Hopes that there would be a straightforward transition of power from President Trump to President-Elect, Joe Biden, was also a factor in the upward move. The FTSE 100 is underperforming when compared with markets in mainland Europe as oil, mining and banking stocks are in the red."

NatWest shed 2.0%, Barclays lost 1.6% while oil major BP fell 1.5%.

Doubts over the efficacy of the AstraZeneca and Oxford University jab emerged on news the dose that was shown to be 90% effective was only tested in people aged 55 and under, according to a US official.

Moncef Slaoui, the scientific head of Operation Warp Speed – the programme to supply the US with vaccines – told US reporters that the half-dose regime, which was discovered by accident, was only given to younger age groups.

Oxford's overall efficacy from two different dosing regimes in a phase three trial was announced last week at a combined figure of 70%. A half dose followed by a full dose was found to be 90% effective according to a subset of data, but efficacy was 62% for people given two full doses.

AstraZeneca shares lost 0.7% on Thursday.

Aviva also ended in the red, losing 0.2%. The insurer said it was making progress on its company simplification strategy and announced a new sustainable dividend policy.

Aviva declared a 7.0 pence per share interim dividend. The insurer currently expects to recommend a final 2020 dividend of 14p per share, subject to a decision to be taken in March 2021. The expected 2020 total dividend of 21.0p per share is then expected to grow by low to mid-single digits, it said. However, the expected total dividend for 2020 is 32% lower than the 30.9p paid out in 2019.

Paddy Power owner Flutter Entertainment topped the blue-chip index, up 4.9%. Earlier this week, the Betting & Gaming Council welcomed UK government clarification that even in the most restrictive tier 3 curbs, bookies will be allowed to lift shutters once again.

The government on Thursday outlined which tiers of restrictions await English regions following the end of the current one-month lockdown.

Much of England is facing tough coronavirus restrictions under the new post-lockdown tier arrangements, with bans on households mixing indoors and curbs on pubs and restaurants.

An online postcode checker went live before the official announcement to Parliament and indicated that Manchester, Birmingham, Hull, Newcastle, Bristol and Kent were among the places facing the toughest restrictions, while London and Liverpool are being placed in tier 2.

The new system will apply from December 2 after England's blanket lockdown ends and restrictions have been tightened after government scientific advisers warned that previous measures had not been effective enough.

Back in London, the pub sector struggled for much of the day on Thursday.

"The rebound in the pub and bar sector, sparked by vaccine breakthroughs, has fizzled out with the dawning realisation that the end of lockdown will offer little short term reprieve," Hargreaves Lansdown analyst Susannah Streeter said.

Marston's and Fuller, Smith & Turner lost 4.2% and 5.4%, respectively, while Mitchells & Butlers shed 0.7% after announcing job cuts.

Birmingham-based Mitchells said it was forced to slash around 1,300 jobs.

It swung to a pretax loss of GBP123 million in the financial year that ended September 26 from a GBP177 million profit the year before. Mitchells & Butlers's revenue decreased 34% to GBP1.48 billion from GBP2.24 billion.

On the AIM market, boohoo Group rose 3.4%, as investors took heart from the fast fashion retailer adding former High Court judge Brian Leveson's oversight to its supply chain probe.

Leveson, famous for chairing the eponymous inquiry into ethics of the UK press in the wake of the phone hacking scandal, will report directly to the boohoo's board. The company said his reports will be published, allowing greater "transparency and further independence to the process".

"The board has committed to deliver real change to the supply chain issues that have been raised this summer by the Sunday Times, Guardian and other media outlets, together with further governance issues that have arisen in recent months," Shore Capital Markets said.

The pound was quoted at USD1.3333 at the London equities close, down from USD1.3382. The euro stood at USD1.1908, down slightly from USD1.1909. Against the Japanese yen, the dollar was trading at JPY104.27, eased from JPY104.38.

A warning from the European Central Bank over the "longer-lasting effects" of the Covid-19 pandemic on Thursday raised hopes that policymakers may increase support measures at the central bank's next meeting in December.

The economic hurt caused by the contagion might have longer-lasting implications than first thought, according to minutes released on Thursday from the October 29 ECB meeting.

"The minutes of the October ECB meeting confirmed that there is a broad majority within the Governing Council in favour of a new round of easing in December," analysts at Oxford Economics said.

Oxford Economics tips the ECB to boost the pandemic emergency purchase programme envelope by another EUR500 billion and extend it to the end of 2021.

An ounce of gold fetched USD1,810.32 at the London equities close, down a notch from USD1,811.61 a day earlier. Brent oil was trading at USD47.77 a barrel, down from USD48.04.

On Friday, US markets close at 1800 GMT, 1300 local time. On the data front, third-quarter GDP numbers from France are released at 0745 GMT before a eurozone consumer confidence print at 1000 GMT.

The corporate calendar has annual results from cocktail bar owner Revolution Bars, half-year numbers from motor dealer Caffyns and a trading statement from newspaper publisher Reach.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
Today 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
Today 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
Today 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.